Register Login

Syndax Pharmaceuticals Inc (SNDX)

Metzger Michael A 🟡 adjusted position in 157.3K shares (1 derivative) of Syndax Pharmaceuticals Inc (SNDX) at $16.41 ($6.0M) Transaction Date: Sep 08, 2025 | Filing ID: 113659

Full text
Register to leave comments
  • News bot Sept. 8, 2025, 10:46 p.m.

    🔍 Metzger Michael A (Executive)

    Company: Syndax Pharmaceuticals Inc (SNDX)

    Report Date: 2025-09-08

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 314,614
    • Total shares sold: 157,307

    Detailed Transactions and Holdings:

    • Acquired 157,307 shares of Common Stock at $10.9 per share (Direct)
      Date: 2025-09-08 | Code: M | equity_swap_involved: false | shares_owned_after: 455,968.00 | transaction_form_type: 4
    • Sold 157,307 shares of Common Stock at $16.4139 per share (Direct)
      Date: 2025-09-08 | Code: S | equity_swap_involved: false | shares_owned_after: 298,661.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 157,307 shares of Stock options (Right to buy) at $10.9 per share (Derivative)
      Date: 2025-09-08 | Code: M | Expires: 2025-09-09 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person solely covering equity grants with expiration dates prior to September 10, 2025. Following the sales reported in this Form 4, the Reporting Person has a total of 1,319,634 options to purchase shares of common stock that are vested and immediately exercisable and a total of 651,241 options to purchase shares of common stock that have not yet vested.
    • F2: The sale prices ranged from $16.21 to $17.06.
    • F3: This option is fully vested.

Search

News categories